A Study Evaluating the Safety and Efficacy of Upadacitinib in Adults With Active Ankylosing Spondylitis

NCT03178487 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

187

Enrollment

INDUSTRY

Sponsor class

Conditions

Ankylosing Spondylitis (AS)

Interventions

DRUG: Upadacitinib
DRUG: Placebo

Sponsor

AbbVie